Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4173-4180.
Prepublished online as a Blood First Edition Paper on March 30, 2004; DOI 10.1182/blood-2003-11-3944.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-3944v1
104/13/4173    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asnafi, V.
Right arrow Articles by Macintyre, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asnafi, V.
Right arrow Articles by Macintyre, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 21, 2003
Accepted March 21, 2004

Age-related phenotypic and oncogenic differences in T-Acute Lymphoblastic Leukemias may reflect thymic atrophy

Vahid Asnafi, Kheira Beldjord, Martha Libura, Patrick Villarese, Corinne Millien, Paola Ballerini, Emilienne Kuhlein, Marina Lafage-Pochitaloff, Eric Delabesse, Olivier Bernard, and Elizabeth Macintyre*

Biological hematology, Necker-Enfants-Malades Hospital, Paris, France; INSERM EMIU210 and University of Paris V, Paris, France
Biological hematology, Necker-Enfants-Malades Hospital, Paris, France
Biological hematology, Armand-Trousseau Hospital, Paris, France
Cytogenetic, Purpan Hospital, Toulouse, France
Cytogenetic, Institut Paoli Calmette, Marseille, France
INSERM EMIU210 and University of Paris V, Paris, France

* Corresponding author; email: elizabeth.macintyre{at}nck.ap-hop-paris.fr.

Post natal thymic involution occurs progressively throughout the first 3 decades of life. It predominantly affects T Cell Receptor (TCR) {alpha}{beta}-lineage precursors, with a consequent proportional increase in multipotent thymic precursors. We show that T Acute Lymphoblastic Leukemias (T-ALLs) demonstrate a similar shift with age from predominantly TCR expressing to an immature (IM0/{delta}/{gamma}) stage of maturation arrest. Half demonstrate HOX11, HOX11L2, SIL-TAL or CALM-AF10 deregulation, with each being associated with an, age independent, specific stage of maturation arrest. HOX11 and SIL-TAL represent {alpha}{beta}-lineage oncogenes, whereas HOX11L2 expression indentifies an intermediate {alpha}{beta}/{gamma}/{delta} lineage stage of maturation arrest. In keeping with preferential {alpha}{beta}-lineage involution, the incidence of SIL-TAL and HOX11L2 deregulation decreased with age. In contrast, HOX11 deregulation became more frequent, suggesting longer latency. TAL1 deregulation is more frequent in {alpha}{beta}-lineage T-ALL, when it is predominantly due to SIL-TAL rearrangements in children but to currently unknown mechanisms in adolescents and adults. LMO2 was more frequently co-expressed with LYL1, predominantly in IM0/{delta}/{gamma}) adult cases, than with TAL1. These age related changes in phenotype and oncogenic pathways probably reflect progressive changes in the thymic population at risk of malignant transformation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
P. Ballerini, J. Landman-Parker, J. M. Cayuela, V. Asnafi, M. Labopin, V. Gandemer, Y. Perel, G. Michel, T. Leblanc, C. Schmitt, et al.
Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome
Haematologica, November 1, 2008; 93(11): 1658 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Baleydier, A.-V. Decouvelaere, J. Bergeron, P. Gaulard, D. Canioni, Y. Bertrand, S. Lepretre, B. Petit, H. Dombret, K. Beldjord, et al.
T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
Clin. Cancer Res., February 1, 2008; 14(3): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bessette, M. L. Lang, R. A. Fava, M. Grundy, J. Heinen, L. Horne, R. Spolski, A. Al-Shami, H. C. Morse III, W. J. Leonard, et al.
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling
Blood, January 1, 2008; 111(1): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. R. Gothert, R. L. Brake, M. Smeets, U. Duhrsen, C. G. Begley, and D. J. Izon
NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis
Blood, November 15, 2007; 110(10): 3753 - 3762.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Bergeron, E. Clappier, I. Radford, A. Buzyn, C. Millien, G. Soler, P. Ballerini, X. Thomas, J. Soulier, H. Dombret, et al.
Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs
Blood, October 1, 2007; 110(7): 2324 - 2330.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Y. I. Chan, G. A. Follows, G. Lacaud, J. E. Pimanda, J.-R. Landry, S. Kinston, K. Knezevic, S. Piltz, I. J. Donaldson, L. Gambardella, et al.
The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype
Blood, March 1, 2007; 109(5): 1908 - 1916.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Natkunam, S. Zhao, D. Y. Mason, J. Chen, B. Taidi, M. Jones, A. S. Hammer, S. Hamilton Dutoit, I. S. Lossos, and R. Levy
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
Blood, February 15, 2007; 109(4): 1636 - 1642.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Soulier, E. Clappier, J.-M. Cayuela, A. Regnault, M. Garcia-Peydro, H. Dombret, A. Baruchel, M.-L. Toribio, and F. Sigaux
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
Blood, July 1, 2005; 106(1): 274 - 286.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Asnafi, A. Buzyn, X. Thomas, F. Huguet, N. Vey, J.-M. Boiron, O. Reman, J.-M. Cayuela, V. Lheritier, J.-P. Vernant, et al.
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study
Blood, April 15, 2005; 105(8): 3072 - 3078.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020